Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors

Up to 35% of aggressive pituitary tumors recur and significantly affect mortality and quality of life. Management can be challenging and often requires multimodal treatment. Current treatment options, including surgery, conventional medical therapies such as dopamine agonists, somatostatin receptor...

Full description

Bibliographic Details
Main Authors: Tae Nakano-Tateno, Kheng Joe Lau, Justin Wang, Cailin McMahon, Yasuhiko Kawakami, Toru Tateno, Takako Araki
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Endocrinology
Subjects:
non-surgical therapy
Temozolomide
CAPTEM
PRRT (Peptide Receptor Radionuclide Therapy)
aggressive pituitary tumors
pituitary carcinomas
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.624686/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.624686/full

Similar Items